Paydirt
WT
Insider

William D. Turner

Chief Regulatory Officer

William D. Turner (Chief Regulatory Officer) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Vera Therapeutics, Inc. (VERA). The largest single filing was $501K of VERA (10,000 sh × $50.08, as filed), executed Dec 15 2025.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
returns measure stock purchases only
Filings, ttm
3
0 buys · 3 sells
Median delay
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$1.4M
shares × price, as filed
Last traded
Dec 15 2025
Filed Dec 17 2025

Median ADV $64.6M across their filed names

Open performance
Volume by month
$1.4M$677K$0Oct 2024Apr 2025Oct 2025Apr 2026Dec 2025 · sells $1.4M
Buys $0 Sells $1.4M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 3 filings

Sector per market data · by filing · past 12 months

Most traded names
VERA Vera Therapeutics, Inc. VERA · 0 buys · 3 sells 3 filings
Recent filings
VERASALE Vera Therapeutics, Inc. View filing → $501K
10,000 sh × $50.08
Exec Dec 15 2025
Filed Dec 17 2025 · 5:30 PM ET
VERASALE Vera Therapeutics, Inc. View filing → $453K
10,000 sh × $45.31
Exec Dec 8 2025
Filed Dec 10 2025 · 5:30 PM ET
VERASALE Vera Therapeutics, Inc. View filing → $400K
10,000 sh × $40.00
Exec Dec 3 2025
Filed Dec 4 2025 · 5:30 PM ET